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Abstract
Background: Vitamin D deficiency is common in obese adolescents and a risk factor for 
insulin resistance. We investigated if prevailing serum 25-OH vitamin D might predict the 
body fat loss in a group of obese adolescents undergoing a residential weight  
loss program.
Methods: In 92 (35 male) obese adolescents (aged 10.6–19 years) undergoing a residential 
weight loss program in Belgium, fasting serum 25-OH vitamin D (25-OH-D), insulin, 
glucose and lipid levels were measured and body composition was assessed by dual-
energy X-ray absorptiometry (DXA).
Results: Baseline median (range) serum 25-OH-D level was 17.7 µg/L (3.8–41.8). In total, 
55 adolescents had a serum 25-OH-D below 20 µg/L. In 31 adolescents with a low 
baseline 25-OH-D level, median increase in serum 25-OH-D was 2.4 µg/L (−4.2 to 7.2) 
after 10 months. This resulted in normal 25-OH-D levels in seven adolescents, whereas 
median BMI decreased with 1.0 SDS and body fat percentage diminished with 9.9%. 
Obese adolescents with or without a 25-OH-D level below or above 20 µg/L at baseline 
had similar changes in body weight, BMI SDS, body fat percentage and body fat mass at 
the end of the program. The change in serum 25-OH-D did not correlate with change in 
serum insulin, BMI SDS or body fat percentage and body fat mass.
Conclusion: Vitamin D deficiency was present in 55 out of 92 obese adolescents at the start 
of the summer. Serum 25-OH-D concentration did not predict changes in body fat loss 
after a residential weight loss program.
Introduction
Obese adolescents are a population known to be at risk 
for vitamin D deficiency, which is defined as a serum 
25-OH-D level below 20 µg/L according to the guidelines 
set by the Endocrine Society (based on the Institute Of 
Medicine (IOM) cut-off) (1, 2, 3). Different mechanisms 
are thought to contribute to the specific vulnerability 
of the obese adolescent to vitamin D deficiency. Firstly, 
there might be less exposure to sunlight due to avoidance 
of outdoor activities and wearing covering clothing (4, 
5, 6). Secondly, there is assumed to be a combination of 
sequestration of the vitamin D in the adipose tissue and 
volume dilatation of the serum (4, 5, 6, 7, 8, 9). A possible 
aberrant negative feedback from 1.25-OH2-D has also been 
hypothesized (4, 9). On the other hand, a less efficient 25 
hydroxylation of vitamin D has been proposed; however, 
this hypothesis remains controversial (6, 10, 11, 12).
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After cutaneous synthesis and intestinal absorption, 
vitamin D is hydroxylated twice to produce the active 
1.25-OH2-D metabolite, which binds to the nuclear 
vitamin D receptor (VDR) in target cells to stimulate 
downstream signaling (11). Since both the pancreatic 
β-cells and the adipocytes express VDR, involvement of 
vitamin D in glucose homeostasis and fat metabolism is 
suggested (4, 9, 11, 13). On the one hand, an influence 
on the glucose homeostasis is hypothesized through less 
production of insulin by the pancreatic β-cells and decreased 
peripheral insulin sensitivity by an increased systemic 
inflammation as 1,25-OH2-D is involved in the inhibition 
of synthesis of Interleukin-6 (IL-6) and tumor necrosis 
factor-α (TNF-α) (14). On the other hand, a stimulation of 
lipogenesis, expansion of triglyceride stores and limitation 
of lipolysis in white fat cells as well increased conversion 
of pre-adipocytes to adipocytes by compensatory elevated 
PTH secretion, has been proposed (9, 15).
Some studies show an increase in 25-OH vitamin D 
level after obtaining weight loss (16, 17). However, the 
possible causal nature of the correlation between body fat 
loss and increased serum 25 OH vitamin D level remains 
controversial. Both obesity and vitamin D deficiency are 
common in adolescents worldwide, and it is possible that 
these conditions are coexistent without any cause and 
effect relationship. Our rationale for thinking there could 
be an effect of vitamin D3 on weight, was that vitamin D 
can affect bodyfat status directly by a direct vitamin D 
receptor-dependent inhibition of the critical molecular 
components of adipogenesis, as well indirectly by inducing 
insulin resistance and elevated PTH concentrations. 
Therefore, the main aim of our study is to investigate 
the predictive value of the vitamin D status in body fat 
loss in obese adolescents during a residential weight loss 
program. We hypothesized that adolescents with a low 
baseline vitamin D level would be at risk for less effective 
weight loss during the interventional program because of 
increased insulin resistance.
Materials and methods
After approval of the Local Ethics Committee of the 
University Hospital of Brussels, informed consent 
forms of the parents as well as assent forms from the 
adolescents were obtained. A total of 92 (35 male) obese 
(BMI SDS >1.8) adolescents aged between 10.6 and 19 
years were prospectively included in July 2012 when 
entering a 10-month residential weight loss program. A 
total of 64 adolescents completed the entire program. 
The explanation for the time delay between data collection 
(2012–2013) and publication (2019) is that the data was 
initially collected as part of planned PhD project, which 
was not completed. The collected data were analyzed for 
the first time and presented at a conference in 2018 by the 
participating investigators.
The residential weight loss program combines a 
nutritional intervention with daily physical activity (18). 
The diet provides between 1500 and 1800 kcal/day and 
the physical activities include an individual program (4 h 
a week) and group activities (regular outdoor activities). 
Adolescents with chronic diseases (e.g. diabetes mellitus 
type 1, rheumatoid arthritis) and malabsorption syndromes 
were excluded as well as adolescents treated with 
corticosteroids, metformin and vitamin D supplementation.
The studied outcomes combined anthropometric, 
densitometric and biochemical measurements. Following 
anthropometric measures were performed at baseline and 
at the end: body weight and height, waist circumference 
and body fat assessment by DXA scan. Standing height was 
measured using a stadiometer with a movable headboard 
and vertical backboard (SECA, Hamburg, Germany); body 
weight was measured in light clothing using a class 3 
SECA weighing scale. The total body fat percentage was 
assessed using a DXA scan (Lunar, GE Healthcare). BMI 
was calculated from measured body weight and body 
height and expressed as SDS according to the Flemish 
growth charts (2014 data). Pubertal development was 
assessed according to Tanner stages.
A blood sample was taken by a venipuncture after 
an overnight fasting at baseline and repeated at the end 
of the program in May 2013 in case of 25-OH vitamin D 
<20 µg/L at baseline. Following biochemical parameters 
were determined using standard laboratory techniques: 
glucose, insulin, total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides and 25-OHD level. Serum 25-OH 
vitamin D was measured by electrochemiluminescence 
(Cobas 8000/Roche Diagnostics). The metabolic 
syndrome was defined by the IDF standards (based on 
waist circumference, blood pressure, triglycerides, HDL 
cholesterol and glucose level) (19).
The adolescents were categorized in different obesity 
stages according to the Flemish Growth charts (20): 
overweight is a BMI SDS between 1.3 and 2.3, stage 1 
obesity is a BMI SDS between 2.3 and 3.0, stage 2 obesity 
is a BMI SDS between 3.0 and 3.5 and stage 3 obesity is a 
BMI SDS above 3.5. Vitamin D deficiency was defined as a 
25-OH-D level below 20 µg/L.
All statistical analysis were performed using 
SPSS, version 25. Paired t-tests for the comparison of 
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repeated-measures and Pearson correlation analysis 
were performed, while Mann–Whitney U test was 
used to compare the anthropometric changes between 
children with a 25-OH vitamin D concentration below 
or above 20 µg/L. P values <0.05 were considered 
statistically significant.
Results
Baseline characteristics and comparison  
between adolescents with a normal or deficient 
vitamin D status
The baseline anthropometric characteristics of the 92 
adolescents at start of the program are summarized 
in Table 1. The vast majority of the adolescents were 
Caucasian (n = 85); other ethnic groups were African (n = 6) 
and Latin (n = 1) adolescents. Three female adolescents 
were at Tanner breast stage 2, 10 at stage 3 and 44 at stages 
4 and 5. Eleven male adolescents were at Tanner genital 2, 
2 at stage 3 and 22 at stages 4 and 5. The 28 adolescents 
leaving the program prematurely were significantly older 
(15.8 vs 14.4 years), smaller (height SD −0.16 vs 0.33) 
and had a higher fat percentage (51.55 vs 50.40%) than 
those who completed the 10-month program, probably 
because of different gender distribution (8/28 males versus 
27/64 males).
Baseline median (range) serum 25-OH-D level was 
17.7 µg/L (3.8–41.8). In total 55 adolescents had a serum 
25-OH-D below 20 µg/L. There was no effect of age, 
gender or pubertal status difference on serum 25-OH 
vitamin D. Baseline serum 25-OH vitamin D was inversely 
correlated with the weight SDS (r = −0.302; P = 0.003) 
and BMI SDS (r = −0.305; P = 0.003), but not with body 
fat percentage (r = 0.043; P = 0.686). When patients 
were categorized according the different obesity stages, 
there was no significant difference (P = 0.092) in 25-OH 
vitamin D levels (Fig. 1). Body fat percentage ranged between 
37.5 and 59.3% (median 50.8%). Females had a higher 
body fat percentage than boys (51.5 vs 48.7%, P = 0.005).
Serum fasting insulin ranged between 36 and 
294 pmol/L, while fasting hyperinsulinemia (>115 pmol/L 
based on the used assay (21)) was present in 43 adolescents. 
The metabolic syndrome defined by the IDF standards 
was present in 47 obese adolescents. Baseline median 
(range) lipid levels were respectively 129 mg/dL total 
cholesterol (75–209), 74 mg/dL LDL cholesterol (29–153), 
37 mg/dL HDL cholesterol (21–72) and 74 mg/dL 
triglycerides (36–189). Dyslipidemia was present in 
60 adolescents, defined as at least one of the following: 
LDL cholesterol above 130 mg/dL, HDL cholesterol below 
40 mg/dL or triglycerides above 130 mg/dL.
Obese adolescents with a low 25-OH-D at the start 
had similar baseline serum insulin concentrations (110 vs 
99 pmol/L), body fat percentage (50.9 vs 50.7%), body fat 
mass (49.4 vs 47.9 kg) and lipid profile (data not shown), 
than those with a normal vitamin D status, as shown 
in Table 2.
Changes in body composition and serum 25-OH 
vitamin D levels
Median decrease in body weight, BMI SDS and body fat 
percentage after 10 months (n = 64) were respectively 
−24.0 kg (−55.2 to +3.4); −1.1 SDS (−2.3 to 0) and −12.3% 
(−38.2 to 0.5) (Fig. 2).
In 31 adolescents with a low baseline 25-OH-D 
(<20 µg/L) and repeated measurements, median serum 
25-OH-D, measured in May, was 16.3 µg/L (6.7–26.6), 
resulting in a median increase of 2.4 µg/L (−4.2 to 7.2) 
(P < 0.001) and a normalization of 25-OH-D levels in 
seven adolescents.
The change in serum 25-OH-D was not related with 
the changes in serum insulin (r = −0.074; P = 0.82), BMI SDS 
(r = −0.332; P = 0.068) or body fat percentage (r = −0.349; 
P = 0.054). Obese adolescents with a low 25-OH-D at the 
start had similar change in weight (−24.4 vs −23.5 kg), 
Table 1 Comparison of anthropometric and biochemical characteristics between obese adolescents leaving and completing the 
weight loss program.
Total group (n = 92) Program not completed (n = 28) Program completed (n = 64) P value
Male/female 35/57 8/20 27/37 0.22
Age (years) 14.7 (10.6–19.0) 15.8 (11.9–19.0) 14.45 (10.6–18.7) 0.002
Weight SDS 2.75 (1.52–4.41) 2.79 (1.52–4.18) 2.75 (1.59–4.41) 0.83
Height SDS 0.26 (−2.48 to 2.84) −0.16 (−2.48 to 1.59) 0.33 (−1.93 to 2.84) 0.01
BMI SDS 2.74 (1.82–4.00) 2.81 (1.96–4.00) 2.62 (1.82–3.91) 0.13
Body Fat (%) 50.80 (37.50–59.30) 51.55 (38.4–56.3) 50.40 (37.5–59.3) 0.05
Values are expressed as median with the range in paracentesis. Bold indicates statistical significance, P < 0.05.
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BMI SDS (−1.1 vs −1.3 SDS) and body fat percentage 
(−11.2 vs −14.9%) after the intervention than those with 
a normal vitamin D status, as shown in Table 2.
Discussion
Vitamin D deficiency was found in more than half of 
obese adolescents at the beginning of a residential weight 
loss program, which resulted in a significant loss in body 
fat percentage with 12.3% and was associated with a 
median increase of circulating 25-OH-D with 2.4 µg/L. 
Less than a quarter of the adolescents with a vitamin D 
deficiency at the start of the program had a normal 
vitamin D status at the end of the intervention. Against 
our expectations, neither baseline serum 25-OH-D nor the 
change in 25-OH-D predicted the weight loss outcomes at 
the end of the program.
Previous studies have identified the obese population 
being especially at risk for vitamin D deficiency. Studies 
regarding the prevalence in obese adolescents are sparser 
than in adults, but still report a high prevalence of 
vitamin D deficiency, ranging from 34 to 100%, regardless 
of the age of the adolescents (2, 3, 7, 8, 11, 15). Serum 
25-OH vitamin D levels however depend greatly on the 
season in North and West European countries, with the 
highest level during the summer time. We found that 
in the month of June, 55 out of a group of 92 Belgian 
obese adolescents were vitamin D deficient. We do 
expect much lower 25-OH-D levels during winter time, 
as we previously observed the highest serum 25-OH-D 
levels from June to September in a Belgian population of 
children and adolescents with cystic fibrosis (22).
Since the adolescents in our residential program 
received a healthy diet and did frequent outdoor activities, 
we expected their vitamin D intake and cutaneous 
vitamin D production to be higher at the end of the 
program. We only observed a slight increase of 2.4 µg/L in 
those adolescents with a low baseline 25-OH-D level. In 
some studies, weight loss in obese adolescents was found 
to result in a subsequent increase of the 25-OH vitamin D 
level ranging from 1.8 to maximum 5 µg/L (16, 17).
Since a vitamin D deficit correlates with insulin 
resistance, we suspected that the low vitamin D status 
at start would play a counteractive role in the weight 
loss process (7). We however did not observe a lower 
weight loss or fat mass loss in those adolescents 
with a vitamin D deficiency. Nevertheless, the vitamin D- 
deficient children in our study had comparable serum 
insulin levels at start of the program, suggesting a 
comparable degree of insulin sensitivity in the 
adolescents both with 25-OH vitamin D levels above 
and below 20 µg/L.
There is still uncertainty whether there is an actual 
causal relationship between the vitamin D and effective 
weight loss. Studies based on bi-directional Mendelian 
randomization analysis argue that vitamin D deficiency 
is rather a cause of the obesity than an actual modulator 
of the weight loss process (23). Since the serum 25-OH-D 
Figure 1
Baseline serum 25-OH-D levels according to different obesity stages.
Table 2 Comparison of groups according to baseline 25-OH-D level above or below 20 µg/L.
Baseline 25-OH-D <20 µg/L (n = 36) Baseline 25-OH-D >20 µg/L (n = 29) P value
Baseline serum insulin (pmol/L) 110 (37–247) 99 (36–294) 0.52
Baseline body fat percentage (%) 50.4 (40.2–59.3) 50.7 (37.5–55.6) 1.0
Baseline body fat mass (kg) 47.8 (29.2–88.7) 47.4 (26.2–83.5) 0.61
Baseline total cholesterol (mg/dL) 127 (75–199) 130 (76–202) 0.61
Baseline LDL cholesterol (mg/dL) 73 (39–117) 77 (29–153) 0.47
Baseline HDL cholesterol (mg/dL) 38 (28–59) 35 (28–54) 0.11
Baseline triglycerides (mg/dL) 78 (42–128) 67 (40–128) 0.61
Change in weight (kg) −24.4 (−52.1 to −8.2) −23.5 (−55.2 to −8.2) 0.61
Change in BMI SDS −1.09 (−2.33 to 0.5) −1.32 (−2.32 to −0.02) 0.13
Change in body fat percentage −11.25 (−38.2 to 0.5) −14.9 (−30.9 to −2.6) 0.10
Data are expressed as median and range.
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changes did not correlate with any changes in body 
composition nor could be used to predict the weight 
outcomes at the end of the program, the actual clinical 
implication of low vitamin D levels seem limited for now, 
based on the current results.
The most important strength of the study is the 
unique study population, resulting from the standardized 
residential multidisciplinary weight loss intervention. 
In terms of standardization, the residential program is 
superior to outpatient regimens, where the amount of 
physical activity and caloric intake are more difficult to 
compare. In our study, we know the adolescents had a 
similar dietary supply of vitamin D and exposure to 
sunlight. Since the serum levels were measured twice 
during the same season, we additionally limited the 
known seasonal variability in the serum levels of 25 OH 
vitamin D. In addition, not only body weight but also 
whole body fat percentage, using well-standardized 
measurement by DXA, was assessed in our study.
The key limitation of our study is the fact that we 
only have a second serum vitamin D measurement 
of a subgroup of adolescents who already started the 
intervention with a value below cut-off. We can only 
speculate whether a higher baseline value would result 
in a more pronounced increase in vitamin D levels after 
the intervention. The significant dropout rate reported in 
our study is due to the residential program offered at the 
Zeepreventorium, in which adolescents are required to 
leave their home-environment for a complete school year, 
putting both physical stress (coping with daily physical 
exercises) and psychological stress (leaving the home-
environment) on the participants.
Future work should focus on the identification of the 
factors contributing to a low vitamin D status in obese 
adolescents as neither age nor body fat percentage are 
involved, suggesting a potential important role for low 
sunshine exposure in this particular population.
Conclusion
Vitamin D deficiency was found in more than half of 
the obese adolescents starting a residential, standardized 
weight loss program. A slight increase of serum 25-OH-D 
was observed at the end in those adolescents who had a 
vitamin D deficiency at the start, resulting in a persistent 
vitamin D deficiency in 77.4%. Obese adolescents with or 
without a vitamin D deficiency at start of the weight loss 
program had similar body fat loss, questioning the need 
for a systematic vitamin D supplementation, at least for 
increasing weight loss.
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